Aravis Ventures Founded 2001
Founders Jean-Philippe Tripet Simon Nebel
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 28
Average round size
info
The average size of a deal this fund participated in
$23M
Portfolio companies 17
Rounds per year 0.85
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.36
Exits 8
Stages of investment
Early Stage Venture
Late Stage Venture
Areas of investment
Biotechnology
Business Development
Consumer Goods
Health Care
Lifestyle
Summary

In 2001 was created Aravis Ventures, which is appeared as VC. The main office of represented VC is situated in the Zu00fcrich. The company was established in Europe in Switzerland.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. The fund has no exact preference in some founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Ikaria, Kalypsys, MerLion Pharma.

The high activity for fund was in 2009. Despite it in 2019 the fund had an activity. Deals in the range of 10 - 50 millions dollars are the general things for fund. This Aravis Ventures works on 3 percentage points more the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2015.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Aravis Ventures, startups are often financed by Novartis Venture Fund, 5AM Ventures, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, M Ventures, Dansk Innovation. In the next rounds fund is usually obtained by Novartis Venture Fund, Dansk Innovation, 5AM Ventures.

This organization was formed by Jean-Philippe Tripet, Simon Nebel. The overall number of key employees were 5.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Athelas
Biotechnology
Health Care
Life Science
Early Stage Venture
15M01 Feb 2019 United States, Mountain View
Bird Rock Bio
Biotechnology
Life Science
Therapeutics
Early Stage Venture
15M27 Mar 2014 United States, San Diego
Synaffix BV
Biotechnology
Therapeutics
Early Stage Venture
18 Feb 2014 Netherlands, " The Netherlands"}
Bellerophon Therapeutics
Biotechnology
Health Care
Medical
Early Stage Venture
80M26 Dec 2013 United States, " United States"}
Synosia Therapeutics
Biotechnology
Drug Discovery
Medical
Pharmaceuticals
Therapeutics
Late Stage Venture
30M12 Oct 2010 Switzerland, Basel
Biotechnology
Pharmaceutical
Late Stage Venture
7M11 Oct 2010 Singapore, Singapore
Evolva
Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
Post-IPO Equity
27M11 Dec 2009 Switzerland, " Switzerland"}
Evolva
Biotechnology
Consulting
Food and Beverage
Health Care
Wellness
Early Stage Venture
29M22 Oct 2009 Switzerland, " Switzerland"}
Symetis
Biotechnology
Health Care
Medical
Early Stage Venture
21M01 Jul 2009 Switzerland, " Switzerland"}
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Aravis Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: